Geneos Wealth Management’s Vicor VICR Stock Holding History

Geneos Wealth Management’s Portfolio VICR Stock Details VICR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$160K	Hold	420	–	–	﹤0.01%	1073
2026 Q1	$67.6K	Hold	420	–	–	﹤0.01%	1311
2025 Q4	$46K	Hold	420	–	–	﹤0.01%	1425
2025 Q3	$20.9K	Buy	+420	New	+$20.5K	﹤0.01%	1707
2025 Q2	–	Sell	-81	Closed	-$3.79K	–	3226
2025 Q1	$3.79K	Buy	+81	New	+$4.29K	﹤0.01%	2601

Other funds holding VICR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Geneos Wealth Management's VICR Position: Q2 2026 in Review

Geneos Wealth Management held its Vicor (VICR) position steady in Q2 2026 at 420 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #1073.

Geneos Wealth Management first reported a position in VICR in Q1 2025 and has held it in 5 quarters since. 514 funds tracked by Wall St. Rank hold VICR as of Q2 2026.

Geneos Wealth Management held 420 shares of Vicor worth $160K as of Q2 2026.
Geneos Wealth Management left its Vicor share count unchanged in Q2 2026.
Vicor made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #1073 holding.
Geneos Wealth Management first reported a position in Vicor in Q1 2025 and has held it in 5 quarters since.
514 funds tracked by Wall St. Rank held Vicor as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.